Jenburkt Pharmaceuticals Limited (JENBURPH.BO)
INR 1028.05
(-1.0%)
INR 1028.05
(-1.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -791.91 Million INR | -10745.18% |
| 2022 | -7.3 Million INR | -142.37% |
| 2021 | 17.23 Million INR | -33.02% |
| 2020 | 25.73 Million INR | -2.74% |
| 2019 | 26.45 Million INR | -57.62% |
| 2018 | 62.42 Million INR | 762.33% |
| 2017 | -9.42 Million INR | -121.48% |
| 2016 | 43.88 Million INR | 2.21% |
| 2015 | 42.93 Million INR | 120.55% |
| 2014 | -208.93 Million INR | -41.86% |
| 2013 | -147.28 Million INR | -115.66% |
| 2012 | -68.29 Million INR | -21.31% |
| 2011 | -56.29 Million INR | -68.81% |
| 2010 | -33.35 Million INR | -361.37% |
| 2009 | 12.76 Million INR | -66.4% |
| 2008 | 37.97 Million INR | -39.51% |
| 2007 | 62.78 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 739.69 Million INR | 193.41% |
| 2023 FY | -791.91 Million INR | -10745.18% |
| 2023 Q4 | -791.91 Million INR | -242.2% |
| 2023 Q3 | 556.89 Million INR | 1471.53% |
| 2023 Q2 | -40.6 Million INR | -108.21% |
| 2023 Q1 | 494.84 Million INR | 6876.83% |
| 2022 Q3 | 488.3 Million INR | 3814.79% |
| 2022 Q2 | -13.14 Million INR | -102.82% |
| 2022 Q1 | 465.85 Million INR | 2602.98% |
| 2022 Q4 | -7.3 Million INR | -101.5% |
| 2022 FY | -7.3 Million INR | -142.37% |
| 2021 Q4 | 17.23 Million INR | -96.49% |
| 2021 Q2 | 3.91 Million INR | -99.25% |
| 2021 FY | 17.23 Million INR | -33.02% |
| 2021 Q1 | 520.07 Million INR | 1921.11% |
| 2021 Q3 | 490.5 Million INR | 12428.74% |
| 2020 Q4 | 25.73 Million INR | -96.21% |
| 2020 Q3 | 678.24 Million INR | 8119.91% |
| 2020 FY | 25.73 Million INR | -2.74% |
| 2020 Q1 | 545.51 Million INR | 1961.91% |
| 2020 Q2 | -8.45 Million INR | -101.55% |
| 2019 FY | 26.45 Million INR | -57.62% |
| 2019 Q4 | 26.45 Million INR | -95.29% |
| 2019 Q3 | 561.19 Million INR | 1867.16% |
| 2019 Q1 | 523.24 Million INR | 738.2% |
| 2019 Q2 | 28.52 Million INR | -94.55% |
| 2018 Q3 | 489.09 Million INR | 1568.91% |
| 2018 FY | 62.42 Million INR | 762.33% |
| 2018 Q4 | 62.42 Million INR | -87.24% |
| 2018 Q2 | 29.3 Million INR | -92.88% |
| 2018 Q1 | 411.59 Million INR | 4467.01% |
| 2017 Q1 | 420.83 Million INR | 859.0% |
| 2017 Q3 | 409.71 Million INR | 205.85% |
| 2017 Q4 | -9.42 Million INR | -102.3% |
| 2017 Q2 | -387.07 Million INR | -191.98% |
| 2017 FY | -9.42 Million INR | -121.48% |
| 2016 Q2 | -339.84 Million INR | -214.67% |
| 2016 FY | 43.88 Million INR | 2.21% |
| 2016 Q1 | 296.35 Million INR | 590.22% |
| 2016 Q4 | 43.88 Million INR | -87.9% |
| 2016 Q3 | 362.76 Million INR | 206.75% |
| 2015 Q2 | -271.31 Million INR | -198.63% |
| 2015 FY | 42.93 Million INR | 120.55% |
| 2015 Q4 | 42.93 Million INR | -85.55% |
| 2015 Q3 | 297.1 Million INR | 209.51% |
| 2015 Q1 | 275.07 Million INR | 231.66% |
| 2014 Q2 | -195.25 Million INR | -216.58% |
| 2014 Q1 | 167.48 Million INR | 213.71% |
| 2014 FY | -208.93 Million INR | -41.86% |
| 2014 Q4 | -208.93 Million INR | -193.56% |
| 2014 Q3 | 223.31 Million INR | 214.37% |
| 2013 Q4 | -147.28 Million INR | -182.45% |
| 2013 Q2 | -148.26 Million INR | -229.97% |
| 2013 Q1 | 114.07 Million INR | 267.03% |
| 2013 FY | -147.28 Million INR | -115.66% |
| 2013 Q3 | 178.64 Million INR | 220.49% |
| 2012 FY | -68.29 Million INR | -21.31% |
| 2012 Q4 | -68.29 Million INR | 0.0% |
| 2011 Q4 | -56.29 Million INR | 0.0% |
| 2011 FY | -56.29 Million INR | -68.81% |
| 2010 FY | -33.35 Million INR | -361.37% |
| 2009 FY | 12.76 Million INR | -66.4% |
| 2008 FY | 37.97 Million INR | -39.51% |
| 2007 FY | 62.78 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| ANG Lifesciences India Limited | 671.01 Million INR | 218.018% |
| Add-Shop E-Retail Limited | 116.24 Million INR | 781.229% |
| Bacil Pharma Limited | 569 Thousand INR | 139276.626% |
| Beryl Drugs Limited | 48.7 Million INR | 1725.842% |
| Cian Healthcare Limited | 544.97 Million INR | 245.313% |
| Colinz Laboratories Limited | -64.3 Million INR | -1131.537% |
| Concord Drugs Limited | 164.48 Million INR | 581.445% |
| Deccan Health Care Limited | -7.07 Million INR | -11091.563% |
| Gennex Laboratories Limited | -552.54 Million INR | -43.321% |
| Gujarat Terce Laboratories Limited | 37.76 Million INR | 2197.01% |
| Ishita Drugs and Industries Limited | -48.09 Million INR | -1546.461% |
| Kerala Ayurveda Limited | 447.82 Million INR | 276.835% |
| Kwality Pharmaceuticals Limited | 921.75 Million INR | 185.914% |
| Mercury Laboratories Limited | -26.72 Million INR | -2862.756% |
| Panchsheel Organics Limited | -157.82 Million INR | -401.78% |
| Parmax Pharma Limited | 51.8 Million INR | 1628.501% |
| Parnax Lab Limited | 787.61 Million INR | 200.546% |
| Patidar Buildcon Limited | 25.12 Million INR | 3251.775% |
| Pharmaids Pharmaceuticals Limited | 37.28 Million INR | 2223.78% |
| Phaarmasia Limited | -4.89 Million INR | -16071.431% |
| Sandu Pharmaceuticals Limited | -11.43 Million INR | -6828.39% |
| Sastasundar Ventures Limited | -297.24 Million INR | -166.415% |
| SHELTER PHARMA LIMITED | -44.62 Million INR | -1674.639% |
| Source Natural Foods and Herbal Supplements Limited | -58.58 Million INR | -1251.714% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 175.641% |
| Sunil Healthcare Limited | 625.4 Million INR | 226.625% |
| Syschem (India) Limited | 3.53 Million INR | 22521.149% |
| Trident Lifeline Limited | 117.56 Million INR | 773.626% |
| Transchem Limited | -3.16 Million INR | -24936.832% |
| Tyche Industries Limited | -788.94 Million INR | -0.377% |
| Vikram Thermo (India) Limited | 38.62 Million INR | 2150.265% |
| Vasundhara Rasayans Limited | -76.15 Million INR | -939.9% |
| Zenith Healthcare Limited | -25.45 Million INR | -3010.795% |
| Zenotech Laboratories Limited | -196.85 Million INR | -302.279% |
| Hindustan Bio Sciences Limited | 25.21 Million INR | 3240.857% |
| KIMIA BIOSCIENCES LIMITED | 431.72 Million INR | 283.43% |
| Chemo Pharma Laboratories Limited | -6.05 Million INR | -12972.219% |
| MedPlus Health Services Limited | 8.67 Billion INR | 109.125% |
| Sanjivani Paranteral Limited. | -85.95 Million INR | -821.367% |
| Smruthi Organics Limited | 111.28 Million INR | 811.584% |
| Trimurthi Limited | -1.17 Million INR | -67113.97% |
| Zenlabs Ethica Limited | 139.54 Million INR | 667.494% |
| Makers Laboratories Limited | 172.59 Million INR | 558.839% |
| Lactose (India) Limited | 373.97 Million INR | 311.758% |
| Bharat Immunologicals & Biologicals Corporation Limited | 689.39 Million INR | 214.872% |
| Roopa Industries Limited | 216.01 Million INR | 466.602% |
| PANJON LTD. | -12.8 Million INR | -6082.972% |
| TIAAN CONSUMER LIMITED | 13.44 Million INR | 5990.033% |
| Anuh Pharma Limited | -69.8 Million INR | -1034.435% |
| Crestchem Limited | -1.45 Million INR | -54514.828% |
| Emmessar Biotech & Nutrition Limited | -60.73 Million INR | -1203.95% |
| PRAVEG LIMITED | -434.98 Million INR | -82.055% |
| Fredun Pharmaceuticals Limited | 1.04 Billion INR | 175.854% |
| Shukra Pharmaceuticals Limited | -68.26 Million INR | -1060.06% |
| Norris Medicines Limited | 214.86 Million INR | 468.57% |
| Denis Chem Lab Limited | -236.28 Million INR | -235.152% |
| Veerhealth Care Limited | -2.38 Million INR | -33103.983% |
| OXYGENTA PHARMACEUTICAL LIMITE | 571.32 Million INR | 238.609% |
| Godavari Drugs Limited | 530.02 Million INR | 249.412% |
| SHAMROCK INDUSTRIAL CO.LTD. | -9.31 Million INR | -8406.069% |
| Ambalal Sarabhai Enterprises Limited | 132.1 Million INR | 699.481% |
| Vivanza Biosciences Limited | 50.02 Million INR | 1683.007% |
| Medi-Caps Limited | -3.21 Million INR | -24539.546% |
| DECIPHER LABS LIMITED | -93.13 Million INR | -750.26% |
| Shree Ganesh Remedies Limited | 201.85 Million INR | 492.315% |
| Gujarat Themis Biosyn Limited | -53.88 Million INR | -1369.666% |
| Bharat Parenterals Limited | 1.48 Billion INR | 153.195% |
| BDH Industries Limited | -164.47 Million INR | -381.495% |
| Vista Pharmaceuticals Limited | 78.7 Million INR | 1106.194% |
| Coral Laboratories Limited | -612.82 Million INR | -29.223% |
| Evoq Remedies Limited | 41.14 Million INR | 2024.553% |
| Trinity League India Limited | -12 Thousand INR | -6599191.667% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 156.764% |
| Natural Capsules Limited | 956.68 Million INR | 182.777% |
| Auro Laboratories Limited | 252.51 Million INR | 413.61% |